27 studies found for:    LY2216684
Show Display Options
Rank Status Study
21 Completed A Safety Study in Patients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: LY2216684
22 Completed A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: LY2216684;   Drug: Methylphenidate;   Drug: Placebo (tablet);   Drug: Placebo (capsule)
23 Completed A Study of LY2216684 in Patients With Major Depression Disorder
Condition: Major Depressive Disorder
Intervention: Drug: LY2216684
24 Completed A Study for Patients With Major Depression
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo;   Drug: escitalopram
25 Completed A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo
26 Completed A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Placebo
27 Completed A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-27) Next Page
Indicates status has not been verified in more than two years